Oragenics (OGEN)
(Real Time Quote from BATS)
$1.06 USD
+0.01 (0.95%)
Updated Jul 24, 2024 11:38 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OGEN 1.06 +0.01(0.95%)
Will OGEN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for OGEN
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
OGEN Stock Earnings: Oragenics Reported Results for Q4 2023
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
Oragenics unveils automated intranasal device for treating concussed patients
Oragenics develops automated intranasal device for concussed patients